Document is current
Any future updates will be listed below
-
Authors
Chiu, Chia-Yu
Patel, Krina
Thomas, Sheeba K.
Khawaja, Fareed
Dailey Garnes, Natalie J. M.
Lee, Hans C.
Ohanian, Maro
Jiang, Ying
Wang, Lan S.
Hwang, Jessica P.
Torres, Harrys A.
- License Information
-
More Information
Article History
Received: 23 September 2022
Accepted: 19 November 2022
First Online: 7 December 2022
Declarations
:
: Dr. Torres is or has been the principal investigator for research grants from the National Cancer Institute, Gilead Sciences, and Merck & Co., Inc., with all funds paid to MD Anderson Cancer Center. Dr. Torres is or has been a paid scientific advisor for AbbVie, Inc., Gilead Sciences, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., and Dynavax Technologies; Dr. Lee is or has been principal investigator for research grants from Amgen, Bristol Myers Squibb, Janssen, GlaxoSmithKline, Regeneron, Takeda Pharmaceuticals. Dr. Lee is or has been a paid scientific advisor for Bristol Myers Squibb, Celgene, Genentech, Karyopharm, Legend Biotech, GlaxoSmithKline, Sanofi, Pfizer, Monte Rosa Therapeutics, Immunitas Therapeutics, Oncopetides, Takeda Pharmaceuticals. MD Anderson Cancer Center is managing the terms of these arrangements in accordance with its conflict-of-interest policies. All other authors report no conflicts of interest.
